Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid

被引:43
作者
Österlund, A [1 ]
Edén, T
Olsson-Liljequist, B
Hæggman, S
Kahlmeter, G
机构
[1] Cent Hosp Vaxjo, Dept Clin Microbiol, SE-35185 Vaxjo, Sweden
[2] Cent Hosp Kristianstad, Dept Clin Microbiol, Kristianstad, Sweden
[3] Swedish Inst Infect Dis Control, Dept Mol Epidemiol & Biotechnol, Solna, Sweden
关键词
D O I
10.1080/0036554021000026926
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An increased incidence of fusidic acid-resistant Staphylococcus aureus strains causing superficial infections among children in Sweden has been noted since the mid-1990s. Based on routine susceptibility testing data from 10 laboratories representing 8/21 Swedish counties during 1990-2001, the increase was first demonstrated in southern Sweden and subsequently became apparent throughout the country. Epidemiological typing using pulsed-field gel electrophoresis of recent isolates of fusidic acid-resistant S. aureus from 11 laboratories representing 8/21 Swedish counties revealed a high degree of similarity of band patterns, indicating a clonal relationship. Data from 1 of the laboratories demonstrated a close connection between this clone and impetigo. Sales statistics showed a pronounced increase in the use of fusidic acid ointments in the 0-12 y age group from 1998 onwards. There was, however, no statistically significant correlation between sales of fusidic acid ointments and resistance among S. aureus strains to fusidic acid.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 18 条
[11]   EPIDEMIOLOGICAL ASPECTS OF IMPETIGO CONTAGIOSA IN WESTERN SWEDEN [J].
MOBACKEN, H ;
HOLST, R ;
WENGSTROM, C ;
HOLM, SE .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1975, 7 (01) :39-44
[12]   A COMPARISON OF SODIUM FUSIDATE OINTMENT AND MUPIROCIN OINTMENT IN SUPERFICIAL SKIN SEPSIS [J].
MORLEY, PAR ;
MUNOT, LD .
CURRENT MEDICAL RESEARCH AND OPINION, 1988, 11 (02) :142-148
[13]   Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK [J].
Ravenscroft, JC ;
Layton, A ;
Barnham, M .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (04) :327-330
[14]  
RUNEHAGEN A, 1999, OKAND SMITTA BLEV BU, V6, P1
[15]   The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a streptococci in Finland [J].
Seppala, H ;
Klaukka, T ;
VuopioVarkila, J ;
Muotiala, A ;
Helenius, H ;
Lager, K ;
Huovinen, P ;
Kontiainen, S ;
Eskola, J ;
Korpela, J ;
KostialaThompson, A ;
Sarkkinen, H ;
Schauman, K ;
Sivonen, A ;
Vaara, M ;
Eerola, E ;
Hiekkaniemi, H ;
Jarvinen, H ;
Klossner, ML ;
Lehtonen, OP ;
Meurman, O ;
Oinonen, S ;
Katila, ML ;
Karkkainen, P ;
Liimatainen, O ;
Vuento, R ;
Nissinen, A ;
Hirvonen, P ;
Kauppinen, M ;
Kirsi, O ;
Larinkari, U ;
Ahonen, E ;
Herva, E ;
Jagerroos, H ;
Koskela, M ;
Lantto, K ;
Ruuska, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) :441-446
[16]  
*SWED REF GROUP AN, 1997, SCAND J INFECT DIS S, V105, P8
[17]   Resistance to fusidic acid [J].
Turnidge, J ;
Collignon, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 :S35-S44
[18]  
TVETEN Y, 2001, NORWEGIAN SURVEILLAN, V40, P1